Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHA:688566)

Market Cap	4.76B -28.4%
Revenue (ttm)	990.68M +9.6%
Net Income	254.07M +17.4%
EPS	1.27 +15.4%
Shares Out	199.43M
PE Ratio	18.79
Forward PE	n/a
Dividend	0.52 (2.19%)
Ex-Dividend Date	Jun 25, 2026

Volume	1,350,300
Open	23.84
Previous Close	23.75
Day's Range	23.46 - 24.10
52-Week Range	22.82 - 44.68
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHA:688566

Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the drug research and development and production in China. The company’s products cover multiple therapeutic areas such as increasing white blood cells, fighting hypertension, enhancing immunity, treating joint diseases, fighting eye infections, treating bronchitis, protecting liver function, etc. It is also developing drugs for the treatment of depression, tumors, stomach and gastric diseases, and other diseases. In addition, the company offers its products in table...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 1,354
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688566

Financial Performance

In 2025, SHA:688566's revenue was 966.07 million, an increase of 7.76% compared to the previous year's 896.53 million. Earnings were 261.61 million, an increase of 19.28%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 29, 2026

Data Sources Report a data error